BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20664421)

  • 1. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management.
    Obstet Gynecol; 2010 Aug; 116(2 Pt 1):469-472. PubMed ID: 20664421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG Committee Opinion No. 436: evaluation and management of abnormal cervical cytology and histology in adolescents.
    Obstet Gynecol; 2009 Jun; 113(6):1422-1425. PubMed ID: 19461460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies for cervical cancer screening in adolescents.
    Gray SH; Walzer TB
    Curr Opin Pediatr; 2004 Aug; 16(4):344-9. PubMed ID: 15273491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening: evidence behind the guidelines.
    Lees BF; Erickson BK; Huh WK
    Am J Obstet Gynecol; 2016 Apr; 214(4):438-443. PubMed ID: 26519782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
    Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
    J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cervical neoplasia: advances in screening and treatment modalities.
    Tierney B; Westin SN; Schlumbrecht MP; Ramirez PT
    Clin Adv Hematol Oncol; 2010 Aug; 8(8):547-55. PubMed ID: 20966891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Screening Rates in a Chart Review of Adolescent Patients at an Academic Institution before and after the Publication of the 2009 American College of Obstetricians and Gynecologists' Recommendations.
    Summers SL; Petzel A; Anderson J; Kenton K
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):258-62. PubMed ID: 26026218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Reynolds EE; Weinstein A; Farid H; Libman H
    Ann Intern Med; 2022 Feb; 175(2):267-275. PubMed ID: 35130045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer.
    Chopra SJ; Mathew A; Maheshwari A; Bhatla N; Singh S; Rai B; Surappa ST; Ghosh J; Sharma D; Bhaumik J; Biswas M; Deodhar K; Popat P; Giri S; Mahantshetty U; Tongaonkar H; Billimaga R; Engineer R; Grover S; Pedicayil A; Bajpai J; Rekhi B; Alihari A; Babu G; Thangrajan R; Menon S; Shah S; Palled S; Kulkarni Y; Gulia S; Naidu L; Thakur M; Rangrajan V; Kerkar R; Gupta S; Shrivastava SK
    J Glob Oncol; 2018 Jul; 4():1-15. PubMed ID: 30085891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Cervical Cancer: Past, Current, and Future].
    Fujiwara K
    Gan To Kagaku Ryoho; 2022 Feb; 49(2):143-144. PubMed ID: 35249047
    [No Abstract]   [Full Text] [Related]  

  • 17. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
    Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
    J Low Genit Tract Dis; 2021 Oct; 25(4):330-331. PubMed ID: 34542089
    [No Abstract]   [Full Text] [Related]  

  • 18. ACOG Committee Opinion No. 817, Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: Correction.
    Obstet Gynecol; 2022 Jan; 139(1):151-152. PubMed ID: 34915538
    [No Abstract]   [Full Text] [Related]  

  • 19. ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression.
    Creinin MD
    Obstet Gynecol; 2022 Dec; 140(6):1079-1080. PubMed ID: 36441935
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinician's Guide to Prevention and Treatment of Osteoporosis.
    Cosman F; de Beur SJ; LeBoff MS; Lewiecki EM; Tanner B; Randall S; Lindsay R;
    Osteoporos Int; 2014 Oct; 25(10):2359-81. PubMed ID: 25182228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.